.png)
.png)
Latest news from BIA
BIA welcomes the announcement of Nicola Blackwood as new Parliamentary Under-Secretary of State for Health
The BIA welcomes the announcement of Nicola Blackwood as new Parliamentary Under-Secretary of State for Health. BIA CEO, Steve Bates OBE, said: “As a former health minister and former chair of the science and technology committee, and serving as a board member of Eagle Genomics, Nicola knows our sector well and is well-placed to hit the ground running. We had a strong relationship with Nicola when she was minister for health, and we look forward to working with her to ensure the UK stays a world-leader in the life sciences.”
BIA responds to the new letter from Government on the medicine supply contingency plan programme
Today the Health Secretary Matt Hancock has written to pharmaceutical companies to update them on progress made on human medicines supply in March 2019 “no deal scenario” with some updates to the Government planning assumptions.
BIA responds to second Life Sciences Sector Deal
Today the government has published the second Life Sciences Sector Deal. The document details both public and private sector investments into the sector, including a £1bn research and development investment from BIA member company UCB and a new partnership between government and industry using artificial intelligence to develop the next generation of treatments.
Action Medical Research for children named BIA Charity of the Year 2019
The BioIndustry Association has today announced that Action Medical Research for children will be its Charity of the Year for 2019. The partnership will be formally launched at the BIA Gala Dinner on 24 January 2019. Proceeds from a silent auction, table donations and pledges on the night will be donated to Action Medical Research for children, and attendees will hear from Simon Harriss, dad to 10-year-old Lily who has a devastating neurological condition called BPAN.
Almac Group extends personalised cancer vaccine production facilities
An announcement from Edinburgh Technopole; Almac Group extends personalised cancer vaccine production facilities
Leaf Expression Systems appoints Richard Hart as Business Development Director
In response to increasing interest in their Hypertrans plant transient expression technology, Leaf Expression Systems have strengthened their team with the appointment of Richard Hart as Business Development Director
Discovery Park kicks off 2019 with focus on business development
Leading UK science campus looks to attract anchor tenant for Building 518 manufacturing facility.
The Oxford Science Park sponsors the OXBA Innovation Award for the fourth year
Oxford, UK, 14 January 2019 - Oxfordshire companies which are progressing valuable innovations can apply now for The Oxford Science Park Innovation Award, one of 2019's Oxfordshire Business Awards (OXBA). The Oxford Science Park, one of the UK's leading parks for science and technology companies, is pleased to be sponsoring the award for the fourth year.
Guest Blog | Cell & Gene Therapy Catapult | Growth in UK Cell and Gene Therapy Industry Continues for Sixth Year Running
Dr Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult The Cell and Gene Therapy Catapult’s databases of UK clinical trial and preclinical activity reveals a surge in cell and gene therapy trials, highlighting the UK’s thriving ecosystem for developing cell and gene therapy products. As we have done for the past six years, we have reviewed and updated the cell and gene therapy clinical trials and preclinical activity databases which provide a highly relevant measure of progress in our field. By comparing the data year on year, we can identify trends and growth areas across the industry within the UK, and I am happy to see that this year’s database has revealed some positive insights:
Video of the Week | Lily's Story
Action Medical Research for children are the BIA Charity of the Year for 2019. Focusing on funding the very best research into childhood diseases, Action Medical Research have been doing ground-breaking work for over 60 years. Joining us at the BIA Gala Dinner, 24 January 2019, are Simon and Samantha Harriss. They will share their daughter Lily's story with us on the night. Lily has a rare and devastating disease called BPAN, which currently has no cure - but research could change that. You can support Action Medical Research through our silent auction on the night, click here to access the auction early.
Policy and Public Affairs at the BIA
The BIA is the UK’s leading trade association for life sciences, and we have an award-winning policy and public affairs team. The work is varied, stimulating, and at times challenging. At the moment, we have two vacancies open in our policy and public affairs team; A Policy and Public Affairs Manager, and a Talent, People and Skills Manager. A job description only tells part of the story, so we sat down with BIA Policy and Projects Manager, Dr. Martin Turner, and BIA Senior Policy and Public Affairs Executive, Eric Johnsson, to find out more about their roles and what working at the BIA is really like.
CEO Update | Monday 14 January 2019
JP Morgan saw key M&A activity, new approaches from key UK pharma, a buzz about cell and gene therapy and concerns about the ongoing impact of the US Government shutdown. I’ve written a short blog on my perspective here. On Brexit, the vote tomorrow is a key watershed, but for our sector we expect ongoing detail from the government on no-deal contingencies. We will focus our analytical and briefing capability on providing members with actionable information, in what is a very uncertain political context.
Please find a selection of featured BIA publications below. To see our full publications library, click here.
Influencing and shaping our sector, BIA update: January - April 2018
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from January to April 2018.
Biotech Financing Update: December 2017 to February 2018
The BIA/Informa Biotech Financing Update: December 2017-February 2018 released today shows that venture capital financing and follow on financing on the public markets are off to a solid start in 2018.
Pipeline Progressing: The UK's Global Bioscience Cluster in 2017
A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.
BIA Best practice guide for communicating R&D
Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole. To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.
